company background image
A377740 logo

BioNote KOSE:A377740 Stock Report

Last Price

₩4.13k

Market Cap

₩421.5b

7D

-1.0%

1Y

-11.4%

Updated

16 Jun, 2024

Data

Company Financials

A377740 Stock Overview

Manufactures and sells in-vitro diagnostic animal medicines in South Korea.

A377740 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends2/6

BioNote, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioNote
Historical stock prices
Current Share Price₩4,130.00
52 Week High₩6,460.00
52 Week Low₩3,800.00
Beta0
1 Month Change-2.25%
3 Month Change-9.23%
1 Year Change-11.37%
3 Year Changen/a
5 Year Changen/a
Change since IPO-61.22%

Recent News & Updates

There May Be Some Bright Spots In BioNote's (KRX:377740) Earnings

May 25
There May Be Some Bright Spots In BioNote's (KRX:377740) Earnings

Recent updates

There May Be Some Bright Spots In BioNote's (KRX:377740) Earnings

May 25
There May Be Some Bright Spots In BioNote's (KRX:377740) Earnings

Shareholder Returns

A377740KR BiotechsKR Market
7D-1.0%-3.1%1.1%
1Y-11.4%12.6%3.7%

Return vs Industry: A377740 underperformed the KR Biotechs industry which returned 12.6% over the past year.

Return vs Market: A377740 underperformed the KR Market which returned 3.7% over the past year.

Price Volatility

Is A377740's price volatile compared to industry and market?
A377740 volatility
A377740 Average Weekly Movement2.4%
Biotechs Industry Average Movement7.7%
Market Average Movement5.0%
10% most volatile stocks in KR Market11.2%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A377740 has not had significant price volatility in the past 3 months.

Volatility Over Time: A377740's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003313n/awww.bionote.co.kr

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents.

BioNote, Inc. Fundamentals Summary

How do BioNote's earnings and revenue compare to its market cap?
A377740 fundamental statistics
Market cap₩421.49b
Earnings (TTM)₩19.17b
Revenue (TTM)₩94.22b

22.0x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A377740 income statement (TTM)
Revenue₩94.22b
Cost of Revenue₩102.91b
Gross Profit-₩8.69b
Other Expenses-₩27.86b
Earnings₩19.17b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)187.87
Gross Margin-9.22%
Net Profit Margin20.35%
Debt/Equity Ratio0%

How did A377740 perform over the long term?

See historical performance and comparison

Dividends

11.9%

Current Dividend Yield

106%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.